Fracture assessment tool risk scores in bone density reports do not change physician prescribing behavior for osteoporosis

American Journal of the Medical Sciences

Volumn 342, Issue 1, 2011, Pages 5-8

  Izuora, Kenneth E ^a,b   Alazraki, Naomi ^a,b   Byrd Sellers, Johnita ^a   Tangpricha, Vin ^a,b   Nanes, Mark S ^a,b,c  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c School of Medicine ^*  (United States)

Author keywords

Bisphosphonate; Densitometry; Fracture; FRAX; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; CONTROLLED STUDY; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE ASSESSMENT TOOL; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 79959886534     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31820aba02     Document Type: Article

References (23)

1. Lindsay R. The menopause and osteoporosis. Obstet Gynecol 1996; 87:16S-9S.
2. Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465-75. (Pubitemid 46797130)
3. National Osteoporosis Foundation. Fast facts on osteoporosis. Washington (DC): National Osteoporosis Foundation; 2008.
4. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington (DC): National Osteoporosis Foundation; 2010. pp. 2-44.
5. USDHHS. Bone health and osteoporosis: A report of the surgeon general. Rockville (MD): USDHHS; 2004.
6. Fleurence RL, Iglesias CP, Johnson JM. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: A structured review of the literature. Pharmacoeconomics 2007;25: 913-33. (Pubitemid 350014526)
7. van Staa TP, Kanis JA, Geusens P, et al. The cost-effectiveness of bisphosphonates in postmenopausal women based on individual longterm fracture risks. Value Health 2007;10:348-57. (Pubitemid 47481106)
8. Dequeker J, Luyten FP. Bone densitometry is not a good predictor of hip fracture. BMJ 2001;323:797-9.
9. Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988;81: 1804-9.
10. Leslie WD, Metge C, Ward L. Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women. Osteoporos Int 2003;14:334-8. (Pubitemid 40824250)
11. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-97.
12. Kanis JA, Oden A, Johansson H, et al. FRAX and its applications to clinical practice. Bone 2009;44:734-43.
13. Tosteson AN, Melton LJ III, Dawson-Hughes B, et al. Cost-effective osteoporosis treatment thresholds: The United States perspective. Osteoporos Int 2008;19:437-47.
14. SAS. SAS technical report R-109, conjoint analysis examples. Cary (NC): SAS Institute; 1993.
15. National Osteoporosis Foundation/International Society for Clinical Densitometry. National Osteoporosis Foundation (NOF)/International Society for Clinical Densitometry (ISCD) FRAX implementation guide. Washington (DC): National Osteoporosis Foundation/International Society for Clinical Densitometry; 2009.
16. World Health Organization. WHO scientific group on the assessment of osteoporosis at the primary health care level. Geneva (Switzerland): WHO; 2007.
17. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
18. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007;18: 1033-46. (Pubitemid 47020000)
19. Iqbal F, Michaelson J, Thaler L, et al. Declining bone mass in men with chronic pulmonary disease: Contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 1999;116: 1616-24. (Pubitemid 30012703)
20. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAM 1999;282:1458-65. (Pubitemid 29493800)
21. Faria C, Wenzel M, Lee KW, et al. A narrative review of clinical inertia: Focus on hypertension. J Am Soc Hypertens 2009;3:267-76.
22. Looker AC, Orwoll ES, Johnston CC Jr, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997;12:1761-8. (Pubitemid 27500187)
23. Looker AC, Dallman PR, Carroll MD, et al. Prevalence of iron deficiency in the United States. JAMA 1997;277:973-6. (Pubitemid 27142364)